Bausch + Lomb Archives - Insight Presented by Prime Creative Media Mon, 02 May 2022 00:53:08 +0000 en-US hourly 1 https://www.insightnews.com.au/wp-content/uploads/2024/02/cropped-Insight-favicon-32x32.png Bausch + Lomb Archives - Insight 32 32 Bausch + Lomb eyes AU$1.2 billion in IPO https://www.insightnews.com.au/bausch-lomb-eyes-au1-2-billion-in-ipo/ Mon, 02 May 2022 06:00:51 +0000 https://www.insightnews.com.au/?p=27007
B+L could have a market value of US$8.4 billion (AU$11.9 b).

Ophthalmic giant Bausch + Lomb (B+L), which is being spun-off from its parent as a pure-play eye health company, has filed to raise up to US$840 million (AU$1.2 billion) in an initial public offering (IPO). OnRead More

The post Bausch + Lomb eyes AU$1.2 billion in IPO appeared first on Insight.

]]>
B+L could have a market value of US$8.4 billion (AU$11.9 b).
Ophthalmic giant Bausch + Lomb (B+L), which is being spun-off from its parent as a pure-play eye health company, has filed to raise up to US$840 million (AU$1.2 billion) in an initial public offering (IPO). On
Read More

The post Bausch + Lomb eyes AU$1.2 billion in IPO appeared first on Insight.

]]> Eyecare spin-off Bausch + Lomb files for IPO https://www.insightnews.com.au/eyecare-spin-off-bausch-lomb-files-for-ipo/ Mon, 17 Jan 2022 06:00:25 +0000 https://www.insightnews.com.au/?p=24886
AcuFocus believes believes B+L is best positioned to educate eye doctors about the IC-8 Apthera lens.

The post Eyecare spin-off Bausch + Lomb files for IPO appeared first on Insight.

]]>
AcuFocus believes believes B+L is best positioned to educate eye doctors about the IC-8 Apthera lens.
Almost 18 months since its parent company announced Bausch + Lomb (B+L) would be spun off as a pure-play eye health company, the entity has filed for an initial public offering (IPO) on the New York and
Read More

The post Eyecare spin-off Bausch + Lomb files for IPO appeared first on Insight.

]]> In pursuit of more precise vitrectomy https://www.insightnews.com.au/in-pursuit-of-more-precise-vitrectomy/ Sun, 05 Dec 2021 22:56:01 +0000 https://www.insightnews.com.au/?p=24140

The post In pursuit of more precise vitrectomy appeared first on Insight.

]]>
Vitrectomy cutters are the fundamental tool for vitreoretinal surgeons. South Australian retinal specialist DR STEWART LAKE discusses one of the latest advances in the field and how it’s
Read More

The post In pursuit of more precise vitrectomy appeared first on Insight.

]]> Rethinking what’s possible with the enVista IOL https://www.insightnews.com.au/rethinking-whats-possible-with-the-envista-iol/ Fri, 07 May 2021 02:00:01 +0000 http://www.insightnews.com.au/?p=20220
The enhanced enVista lens material enables the lens to unfold much faster.

The post Rethinking what’s possible with the enVista IOL appeared first on Insight.

]]>
The enhanced enVista lens material enables the lens to unfold much faster.
Bausch + Lomb’s latest version of the enVista monofocal recently became available to Australian and New Zealand surgeons along with a new pre-loaded delivery system. Early adopters discuss
Read More

The post Rethinking what’s possible with the enVista IOL appeared first on Insight.

]]> Twin licensing deals bolster Bausch + Lomb’s myopia portfolio https://www.insightnews.com.au/twin-licensing-deals-bolster-bausch-lombs-myopia-portfolio/ Tue, 27 Oct 2020 22:16:45 +0000 http://www.insightnews.com.au/?p=17426 multifocal contact lenses atropine myopia
The efficacy of combined use of multifocal contact lenses and and 0.01% atropine remains unclear.

The post Twin licensing deals bolster Bausch + Lomb’s myopia portfolio appeared first on Insight.

]]> multifocal contact lenses atropine myopia
The efficacy of combined use of multifocal contact lenses and and 0.01% atropine remains unclear.
Bausch + Lomb has acquired an exclusive license for a novel myopia control contact lens developed by a Sydney ophthalmic research institute, just days after signing another deal to commercialise an investigational
Read More

The post Twin licensing deals bolster Bausch + Lomb’s myopia portfolio appeared first on Insight.

]]> TGA approves ‘breakthrough’ B+L contact lens https://www.insightnews.com.au/tga-approves-breakthrough-bl-contact-lens/ Mon, 24 Aug 2020 03:39:15 +0000 http://www.insightnews.com.au/?p=16363
The TGA took just two weeks to approve the contact lens.

The post TGA approves ‘breakthrough’ B+L contact lens appeared first on Insight.

]]>
The TGA took just two weeks to approve the contact lens.
Bausch + Lomb has obtained regulatory approval to supply its new Ultra One Day daily disposable silicone hydrogel (SiHy daily) contact lenses in Australia. The new lens design was recently cleared by the
Read More

The post TGA approves ‘breakthrough’ B+L contact lens appeared first on Insight.

]]> Most trusted industry brands revealed https://www.insightnews.com.au/most-trusted-eyecare-brands-revealed/ Mon, 04 May 2020 04:38:08 +0000 http://www.insightnews.com.au/?p=14434

The post Most trusted industry brands revealed appeared first on Insight.

]]>
Specsavers, OPSM and Bausch + Lomb have featured in the eyecare categories of the 2020 Australian Trusted Brands Survey, while Guide Dogs Australia emerged as the top charity. Research company
Read More

The post Most trusted industry brands revealed appeared first on Insight.

]]>